Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021.
Intern Med J
; 53(2): 275-279, 2023 02.
Article
in English
| MEDLINE | ID: covidwho-2281241
ABSTRACT
Within the first 4 months of the Western Australian COVID-19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevria and Comirnaty administered respectively.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
/
Anaphylaxis
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Oceania
Language:
English
Journal:
Intern Med J
Journal subject:
Internal Medicine
Year:
2023
Document Type:
Article
Affiliation country:
Imj.16001
Similar
MEDLINE
...
LILACS
LIS